NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
07/03/2025
Back to search
Official data from USPTO
REDHILL BIOPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
07/22/2025
Trademark type
Combined
Nice classes
5
Filing date
07/16/2013
Registration date
05/26/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/03/2025
Last transaction
07/22/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2013-09-00
First use in commerce
2013-09-00
Drawing code
3
Owner type
16
Owner location
Tel-Aviv, IL
Examiner
JENKINS JR, CHARLES
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the words "RedHill Biopharma" in black in a stylized format with a picture of a red hill in the color red behind the word "Redhill".
Holders and representatives
Holders
RedHill Biopharma Ltd.
Representatives
Joseph Agostino GREENBERG TRAURIG, LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for treatment of heart failureleft ventricular dysfunction and hypertension; pharmaceutical preparations for treatment of nausea and vomiting for cancer patients; pharmaceutical preparations for treatment of migraines; pharmaceutical preparations for treatment of Crohn's disease; pharmaceutical preparations for treatment of multiple sclerosis disease; pharmaceutical preparations for treatment of H. pylori infections; pharmaceutical preparations for bowel preparation for GI tract procedures; Pharmaceutical preparations for treatment of immune diseases; pharmaceutical preparations for treatment of bacterial infections; diagnostic preparations for diagnosis of bacterial infections for medical purposes
Publications
History of USPTO decisions and trademark events.
39 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
07/03/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
07/03/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/30/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
01/27/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/26/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08/26/2021
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/26/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/26/2021
E815
TEAS SECTION 8 & 15 RECEIVED
05/05/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/26/2020
CORV
REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED
12/06/2018
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
12/06/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
05/26/2015
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/21/2015
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/20/2015
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/30/2015
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/25/2015
IUAF
USE AMENDMENT FILED
02/18/2015
EISU
TEAS STATEMENT OF USE RECEIVED
02/18/2015
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/04/2014
EX1G
SOU EXTENSION 1 GRANTED
09/02/2014
EXT1
SOU EXTENSION 1 FILED
09/02/2014
EEXT
SOU TEAS EXTENSION RECEIVED
09/02/2014
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/04/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/07/2014
PUBO
PUBLISHED FOR OPPOSITION
01/07/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/18/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/03/2013
ALIE
ASSIGNED TO LIE
11/30/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/05/2013
XAEC
EXAMINER'S AMENDMENT ENTERED
11/05/2013
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/05/2013
GNEA
EXAMINERS AMENDMENT E-MAILED
11/05/2013
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/05/2013
DOCK
ASSIGNED TO EXAMINER
10/29/2013
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/24/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/23/2013
NWAP
NEW APPLICATION ENTERED
07/19/2013
Continuous trademark protection
Get notified about every new filing that threatens REDHILL BIOPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.